LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Mitchell A. Jackson, MD, discusses his practice’s experience participating in a real-world study investigating Dexycu (dexamethasone intraocular suspension 9%, EyePoint).
Uncategorized
VIDEO: Dexycu effective in real-world trial